FDA Import Refusal 799-9700841-1/31/1 — MMC HEALTHCARE LTD.
The FDA refused shipment 799-9700841-1/31/1 from MMC HEALTHCARE LTD. (India) on July 21, 2022. The refused product falls under Drugs and Biologics — ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC). Cited charges: 118,3280,75 This firm has 4 other import refusals on record.
Refusal Details
- Date
- July 21, 2022
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61JCA08 ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
- Charges
- 118,3280,75